Trials / Completed
CompletedNCT06938165
The Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host Disease
The Safety and Efficacy of Fecal Microbiota Transplant for Steroid-refractory Graft-versus-host Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This clinical study evaluates the safety and efficacy of fecal microbiota transplantation (FMT) in patients with steroid-refractory graft-versus-host disease (GVHD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fecal Microbiota Transplant (FMT) | FMT in patients with refractory GVHD |
Timeline
- Start date
- 2020-04-27
- Primary completion
- 2024-06-30
- Completion
- 2024-06-30
- First posted
- 2025-04-22
- Last updated
- 2025-04-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06938165. Inclusion in this directory is not an endorsement.